GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Protagenic Therapeutics Inc (STU:MBP) » Definitions » Cyclically Adjusted Book per Share

Protagenic Therapeutics (STU:MBP) Cyclically Adjusted Book per Share : €5.44 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Protagenic Therapeutics Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Protagenic Therapeutics's adjusted book value per share for the three months ended in Mar. 2024 was €0.442. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €5.44 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -84.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Protagenic Therapeutics was -9.60% per year. The lowest was -84.90% per year. And the median was -27.55% per year.

As of today (2024-05-26), Protagenic Therapeutics's current stock price is €1.42. Protagenic Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €5.44. Protagenic Therapeutics's Cyclically Adjusted PB Ratio of today is 0.26.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Protagenic Therapeutics was 0.27. The lowest was 0.00. And the median was 0.00.


Protagenic Therapeutics Cyclically Adjusted Book per Share Historical Data

The historical data trend for Protagenic Therapeutics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Protagenic Therapeutics Cyclically Adjusted Book per Share Chart

Protagenic Therapeutics Annual Data
Trend Jun14 Jun15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 1,576.16 -1,860.48 5.64

Protagenic Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -268.81 6.33 6.32 5.64 5.44

Competitive Comparison of Protagenic Therapeutics's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Protagenic Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Protagenic Therapeutics's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Protagenic Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Protagenic Therapeutics's Cyclically Adjusted PB Ratio falls into.



Protagenic Therapeutics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Protagenic Therapeutics's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.442/131.7762*131.7762
=0.442

Current CPI (Mar. 2024) = 131.7762.

Protagenic Therapeutics Quarterly Data

Book Value per Share CPI Adj_Book
201406 -2.923 100.560 -3.830
201409 -16.462 100.428 -21.601
201412 -33.846 99.070 -45.020
201503 -55.538 99.621 -73.464
201506 -68.769 100.684 -90.006
201509 -86.769 100.392 -113.895
201512 -111.846 99.792 -147.693
201603 416.615 100.470 546.429
201606 131.784 101.688 170.777
201609 1.261 101.861 1.631
201612 0.916 101.863 1.185
201703 0.794 102.862 1.017
201706 0.651 103.349 0.830
201709 0.550 104.136 0.696
201712 0.402 104.011 0.509
201803 0.305 105.290 0.382
201806 0.187 106.317 0.232
201809 0.108 106.507 0.134
201812 -0.072 105.998 -0.090
201903 -0.125 107.251 -0.154
201906 -0.131 108.070 -0.160
201909 -0.129 108.329 -0.157
201912 -0.223 108.420 -0.271
202003 -0.207 108.902 -0.250
202006 -0.258 108.767 -0.313
202009 -0.335 109.815 -0.402
202012 -0.365 109.897 -0.438
202103 -0.628 111.754 -0.741
202106 2.204 114.631 2.534
202109 2.080 115.734 2.368
202112 2.045 117.630 2.291
202203 1.836 121.301 1.995
202206 1.808 125.017 1.906
202209 1.725 125.227 1.815
202212 1.511 125.222 1.590
202303 1.386 127.348 1.434
202306 1.154 128.729 1.181
202309 0.898 129.860 0.911
202312 0.758 129.419 0.772
202403 0.442 131.776 0.442

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Protagenic Therapeutics  (STU:MBP) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Protagenic Therapeutics's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=1.42/5.44
=0.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Protagenic Therapeutics was 0.27. The lowest was 0.00. And the median was 0.00.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Protagenic Therapeutics Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Protagenic Therapeutics's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Protagenic Therapeutics (STU:MBP) Business Description

Traded in Other Exchanges
Address
149 Fifth Avenue, Suite 500, New York, NY, USA, 10010
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-based and brain active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.

Protagenic Therapeutics (STU:MBP) Headlines

No Headlines